Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001161697-19-000512
Filing Date
2019-12-04
Accepted
2019-12-04 17:18:02
Documents
1
Period of Report
2019-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 FOR 12-02-2019 form_4.html 4  
1 FORM 4 FOR 12-02-2019 form_4.xml 4 6320
  Complete submission text file 0001161697-19-000512.txt   7925
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 355 ALHAMBRA CIRCLE CORAL GABLES FL 33134
Business Address
Elsbernd Brian (Reporting) CIK: 0001763511 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33057 | Film No.: 191268855